Dr. Mustafa Al-Shagga obtained his degree in Medicine (MD) from Aden University, Yemen. He worked as Medical Officer in a teaching hospital and a trainee lecturer of Pharmacology. He completed a Master in Medical Sciences (Pharmacology) from National University of Malaysia. He worked as a lecturer then senior lecturer in Cyberjaya University College of Medical Sciences (CUCMS). He joined Newcastle University Medicine Malaysia as a senior lecturer then appointed as Assistant Professor in University of Nottingham Malaysia Campus. Currently he is Associate Professor in the Division of Biomedical Sciences, School of Pharmacy. He recognised as Fellow of a Higher Education Academy (FHEA) (UK) in 2016, and currently he entitled a Senior Fellow (SFHEA).
Teaching & Learning is something of a great deal to me. I have used many ways of teaching pharmacology, video, play-role, debates, team-based, case-based, practical, added to the traditional teaching. Designing and measuring students learning. Designing modules and courses.
Pain physiology and pharmacology
Neurobiology of Depression, Migraine and Obesity
Physiology & Pharmacology of Autonomic Nervous System
ADME for MPharm
Currently I am interested in
1. Educational experimental research in areas of medical education particular interest in students' engagment and improving teaching material using eye-tracking technique
2. Pharmacology of Khat (Catha edulis) & Obesity.
3. Systematic reviews
SEYEDAN, ATEFEHALSADAT, MOHAMED, ZAHURIN, ALSHAGGA, MUSTAFA AHMED, KOOSHA, SANAZ and ALSHAWSH, MOHAMMED A, 2019. Cynometra cauliflora Linn. Attenuates metabolic abnormalities in high-fat diet-induced obese mice. Journal of ethnopharmacology. 236, 173-182
LIM, SHAROEN YU MING, BINTI AZIDIN, ATHIRA RAFHANA, UNG, YEE TZE, AL-SHAGGA, MUSTAFA, ALSHAWSH, MOHAMMED ABDULLAH, MOHAMED, ZAHURIN, ONG, CHIN ENG and PAN, YAN, 2019. Effect of 95% Ethanol Khat Extract and Cathinone on in vitro Human Recombinant Cytochrome P450 (CYP) 2C9, CYP2D6, and CYP3A4 Activity. European journal of drug metabolism and pharmacokinetics.
Pharmacogenetics of Phase 1 & 2 CYP-450 metabolising enzymes